122 related articles for article (PubMed ID: 20815376)
1. Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures.
Wei Y; Tong J; Taylor P; Strumpf D; Ignatchenko V; Pham NA; Yanagawa N; Liu G; Jurisica I; Shepherd FA; Tsao MS; Kislinger T; Moran MF
J Proteome Res; 2011 Jan; 10(1):161-74. PubMed ID: 20815376
[TBL] [Abstract][Full Text] [Related]
2. Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches.
Zhang W; Wei Y; Ignatchenko V; Li L; Sakashita S; Pham NA; Taylor P; Tsao MS; Kislinger T; Moran MF
Proteomics; 2014 Mar; 14(6):795-803. PubMed ID: 24453208
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of S100A7 associated with lung squamous cell carcinoma metastasis to brain.
Zhang H; Wang Y; Chen Y; Sun S; Li N; Lv D; Liu C; Huang L; He D; Xiao X
Lung Cancer; 2007 Jul; 57(1):37-45. PubMed ID: 17418446
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of the human urinary proteome by 1D SDS-PAGE and chip-HPLC-MS/MS identification of the AACT putative urinary biomarker.
Zhang Y; Li Y; Qiu F; Qiu Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3395-401. PubMed ID: 21093387
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.
Rusch V; Klimstra D; Linkov I; Dmitrovsky E
Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers.
Au NH; Cheang M; Huntsman DG; Yorida E; Coldman A; Elliott WM; Bebb G; Flint J; English J; Gilks CB; Grimes HL
J Pathol; 2004 Sep; 204(1):101-9. PubMed ID: 15307143
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.
Rusch V; Baselga J; Cordon-Cardo C; Orazem J; Zaman M; Hoda S; McIntosh J; Kurie J; Dmitrovsky E
Cancer Res; 1993 May; 53(10 Suppl):2379-85. PubMed ID: 7683573
[TBL] [Abstract][Full Text] [Related]
8. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment.
Bijian K; Mlynarek AM; Balys RL; Jie S; Xu Y; Hier MP; Black MJ; Di Falco MR; LaBoissiere S; Alaoui-Jamali MA
J Proteome Res; 2009 May; 8(5):2173-85. PubMed ID: 19284786
[TBL] [Abstract][Full Text] [Related]
9. Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma.
Dacic S; Flanagan M; Cieply K; Ramalingam S; Luketich J; Belani C; Yousem SA
Am J Clin Pathol; 2006 Jun; 125(6):860-5. PubMed ID: 16690485
[TBL] [Abstract][Full Text] [Related]
10. Co-overexpression of fibroblast growth factor 3 and epidermal growth factor receptor is correlated with the development of nonsmall cell lung carcinoma.
Tai AL; Sham JS; Xie D; Fang Y; Wu YL; Hu L; Deng W; Tsao GS; Qiao GB; Cheung AL; Guan XY
Cancer; 2006 Jan; 106(1):146-55. PubMed ID: 16329133
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.
Volante M; Saviozzi S; Rapa I; Ceppi P; Cappia S; Calogero R; Novello S; Borasio P; Papotti M; Scagliotti GV
Cancer; 2007 Sep; 110(6):1321-8. PubMed ID: 17647268
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E
Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714
[TBL] [Abstract][Full Text] [Related]
13. The cell line secretome, a suitable tool for investigating proteins released in vivo by tumors: application to the study of p53-modulated proteins secreted in lung cancer cells.
Chenau J; Michelland S; de Fraipont F; Josserand V; Coll JL; Favrot MC; Seve M
J Proteome Res; 2009 Oct; 8(10):4579-91. PubMed ID: 19639960
[TBL] [Abstract][Full Text] [Related]
14. Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas.
Dobashi Y; Suzuki S; Kimura M; Matsubara H; Tsubochi H; Imoto I; Ooi A
Hum Pathol; 2011 Feb; 42(2):214-26. PubMed ID: 21040950
[TBL] [Abstract][Full Text] [Related]
15. Protein expression in human non-small cell lung cancer: a systematic database.
Bührens RI; Amelung JT; Reymond MA; Beshay M
Pathobiology; 2009; 76(6):277-85. PubMed ID: 19955839
[TBL] [Abstract][Full Text] [Related]
16. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study.
Lee HJ; Xu X; Choe G; Chung DH; Seo JW; Lee JH; Lee CT; Jheon S; Sung SW; Chung JH
Lung Cancer; 2010 Jun; 68(3):375-82. PubMed ID: 19712993
[TBL] [Abstract][Full Text] [Related]
17. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].
Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807
[TBL] [Abstract][Full Text] [Related]
18. Differential ErbB receptor expression and intracellular signaling activity in lung adenocarcinomas and squamous cell carcinomas.
López-Malpartida AV; Ludeña MD; Varela G; García Pichel J
Lung Cancer; 2009 Jul; 65(1):25-33. PubMed ID: 19046792
[TBL] [Abstract][Full Text] [Related]
19. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
20. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
